Dermatology News and Research

Latest Dermatology News and Research

Frequent consumption of citrus fruits may increase risk of skin cancer

A new analysis of dietary patterns among more than 100,000 Americans suggests that frequent consumption of citrus -- namely whole grapefruit and orange juice -- may be associated with an increased risk of melanoma.

2 Jul 2015

Dynatronics completes $4,025,000 private placement financing

Dynatronics Corporation, a manufacturer and marketer of rehabilitation and physical therapy products, announced today that it has completed its $4,025,000 private placement financing led by affiliates of Prettybrook Partners LLC (collectively, "Prettybrook"), a strategic private equity investor focused on the healthcare industry.

1 Jul 2015

BioPharmX announces closure of previously announced underwritten public offering of common stock

BioPharmX Corporation today announced the closing of its previously announced underwritten public offering of 3,636,364 shares of its common stock at a price to the public of $2.75 per share.

1 Jul 2015

Males may play positive role in development of offspring's brains before pregnancy

A new study from Indiana University provides evidence in mice that males may play a positive role in the development of offspring's brains starting before pregnancy.

1 Jul 2015

First participant enrolled in RepliCel's RCT-01 Phase 1/2 clinical trial for treatment of chronic tendinosis

RepliCel Life Sciences Inc., a clinical stage regenerative medicine company focused on the development of autologous cell therapies, announced today that the first participant in its Phase 1/2 clinical trial of RCT-01, being tested for the treatment of chronic unilateral Achilles tendinosis, has been enrolled and their tissue biopsy sent for processing prior to intra-tendon ultrasound-guided injections.

30 Jun 2015

Clinical data demonstrates safe administration of Pexa-Vec in patients with metastatic colorectal cancer

SillaJen, Inc., a private clinical-stage biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, today announced a publication of data demonstrating that in a Phase Ib trial of Pexa-Vec, patients received multiple bi-weekly doses of its lead product Pexa-Vec, representing the first report of multiple intravenous administrations of an oncolytic vaccinia.

29 Jun 2015

Newcastle University scientists document action spectrum of ultraviolet damage in skin cells

Scientists at Newcastle University have documented for the first time the DNA damage which can occur to skin across the full range of ultraviolet radiation from the sun providing an invaluable tool for sun-protection and the manufacturers of sunscreen.

27 Jun 2015

Researchers develop protective vaccine against chlamydia infections

Chlamydiae are the most common, sexually transmitted, bacterial pathogens in the world. Every year around 100 million people contract Chlamydia infections, which are one of the main causes of female infertility and ectopic pregnancies and can also lead to blindness - especially in developing countries.

25 Jun 2015

Many people seem confused by sunscreen terminology

Consumers may need more help navigating the sunscreen aisle. A new Northwestern Medicine study found that many people seem to be confused by sunscreen terminology.

18 Jun 2015

Melanoma patients with high levels of H2A.Z.2 protein less likely to survive

Melanoma patients with high levels of a protein that controls the expression of pro-growth genes are less likely to survive, according to a study led by researchers at Icahn School of Medicine at Mount Sinai and published online in the journal Molecular Cell.

18 Jun 2015

PAH diagnosis delayed for adult congenital heart disease patients

Pulmonary arterial hypertension is often not diagnosed in adult patients with congenital heart disease until 6 years or more after their symptoms first appear, research shows.

17 Jun 2015

Atopix raises additional development capital to investigate OC459 for treatment of asthma

Atopix Therapeutics Limited, a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product OC459 for the treatment of asthma.

17 Jun 2015

TUSM researchers reveal how scratching evokes pleasurable sensation in chronic itch patients

It's long been known that scratching evokes a rewarding and pleasurable sensation in patients with chronic itch. Now, researchers in the Department of Dermatology and Temple Itch Center at Temple University School of Medicine may be closer to understanding why.

16 Jun 2015

A third of people avoid social situations due to uncontrolled dandruff, reveals anonymous survey

A third of people admitted to avoiding social situations as a result of emotional distress caused by their dandruff, according to new survey results released today by the British Skin Foundation(BSF) in conjunction with the world’s no. 1 anti-dandruff shampoo, Head & Shoulders (H&S).

12 Jun 2015

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

Tioga Pharmaceuticals, a clinical stage biotechnology company, today announced the initiation of a Phase 2 clinical study of asimadoline, a novel, well-studied kappa-opioid receptor specific agonist, for the treatment of pruritus or itching. The double-blind, placebo-controlled clinical study is designed to evaluate the safety, tolerability, and clinical efficacy of asimadoline in patients with pruritus due to atopic dermatitis and is being conducted at 20 clinical study centers in the United States.

11 Jun 2015

Ixekizumab drug shows quick and extensive improvements in patients with psoriasis

A University of Manchester led trial of a new psoriasis drug has resulted in 40 percent of people showing a complete clearance of psoriatic plaques after 12 weeks of treatment and over 90 percent showing improvement.

11 Jun 2015

LEO Pharma reports encouraging data from PSO-FAST clinical trial of Enstilar for psoriasis treatment

LEO Pharma A/S today announced that new data being presented at the 23rd World Congress of Dermatology shows aerosol foam Enstilar® (calcipotriol/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g), the Company's dual-action investigational aerosol foam for the treatment of psoriasis vulgaris, provided rapid itch relief and improvements in itch-related sleep loss for patients suffering from psoriasis.

10 Jun 2015

Dermatology News and Research

Latest Dermatology News and Research

Frequent consumption of citrus fruits may increase risk of skin cancer

Dynatronics completes $4,025,000 private placement financing

BioPharmX announces closure of previously announced underwritten public offering of common stock

Males may play positive role in development of offspring's brains before pregnancy

First participant enrolled in RepliCel's RCT-01 Phase 1/2 clinical trial for treatment of chronic tendinosis

Clinical data demonstrates safe administration of Pexa-Vec in patients with metastatic colorectal cancer

Newcastle University scientists document action spectrum of ultraviolet damage in skin cells

Researchers develop protective vaccine against chlamydia infections

Many people seem confused by sunscreen terminology

Melanoma patients with high levels of H2A.Z.2 protein less likely to survive

PAH diagnosis delayed for adult congenital heart disease patients

Atopix raises additional development capital to investigate OC459 for treatment of asthma

TUSM researchers reveal how scratching evokes pleasurable sensation in chronic itch patients

A third of people avoid social situations due to uncontrolled dandruff, reveals anonymous survey

Tioga Pharmaceuticals announces commencement of asimadoline Phase 2 study for treatment of pruritus

Ixekizumab drug shows quick and extensive improvements in patients with psoriasis

LEO Pharma reports encouraging data from PSO-FAST clinical trial of Enstilar for psoriasis treatment

New PlasmaDerm solution facilitates faster healing of wounds

UT Southwestern researchers reveal how the body controls glucose transport

Simon Fraser University's Maryam Sadeghi to unveil MoleScope at World Congress of Dermatology

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Dermatology News and Research

Latest Dermatology News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in